Darmstadt

Merck KGaA Says FDA Extends Review of MS Pill in Setback Against Novartis
Bloomberg
Sat, 11/27/10 - 01:15 pm
Merck KGaA
FDA
MS
multiple sclerosis
Novartis
Darmstadt